Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls
Abstract Introduction The activated partial thromboplastin time (aPTT) and the prothrombin time (PT) are widely available coagulation parameters which are however poor predictors of the anticoagulant effect of direct oral anticoagulants (DOACs). Some coagulometers use the clot waveform analysis (CWA...
Main Authors: | Jonathan Evrard, Romain Siriez, Céline Bouvy, Julien Favresse, Halil Yildiz, Philippe Hainaut, François Mullier, Jean‐Michel Dogné, Jonathan Douxfils |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12804 |
Similar Items
-
The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
by: Romain Siriez, et al.
Published: (2022-03-01) -
Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study
by: Wan Hui Wong, et al.
Published: (2023-07-01) -
Comparison of results obtained using clot-fibrinolysis waveform analysis and global fibrinolysis capacity assay with rotational thromboelastography
by: Takumi Tsuchida, et al.
Published: (2024-03-01) -
Utility of clot waveform analysis in Russell's viper bite victims with hematotoxicity
by: Siju V Abraham, et al.
Published: (2018-01-01) -
A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator
by: Chunli Gao, et al.
Published: (2022-07-01)